quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:18:04·491d
INSIDERFiling
Catalent Inc. logo

Director Ryan Michelle R returned 10,835 shares to the company, closing all direct ownership in the company (SEC Form 4)

CTLT· Catalent Inc.
Health Care
Original source

Companies

  • CTLT
    Catalent Inc.
    Health Care

Recent analyst ratings

  • Nov 16UpdateRobert W. Baird$53.00
  • Sep 5UpdateArgus$62.00
  • Jul 20UpdateWells Fargo$43.00
  • Jul 5UpdateJP Morgan$45.00
  • Jun 14UpdateJefferies$44.00
  • May 22UpdateJP Morgan$45.00

Related

  • PR428d
    Catalent Announces New Board Appointments
  • SEC480d
    SEC Form 15-12G filed by Catalent Inc.
  • PR491d
    Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400
  • INSIDER491d
    Group Pres. Pharma & Consumer Gennadios Aristippos returned 135,286 shares to the company and was granted 21,562 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER491d
    Group President, Biologics Mcerlane David returned 47,730 shares to the company and was granted 11,426 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER491d
    Chief Accounting Officer Hatzfeld Michael returned 16,676 shares to the company and was granted 3,144 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER491d
    SVP, Quality & Reg. Affairs Gunther Scott returned 52,573 shares to the company and was granted 12,938 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER491d
    SVP, General Counsel, CCO Ferraro Joseph Anthony was granted 14,265 shares and returned 38,232 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022